Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
32.8%
% of BBP's 65 holdings also in WDNA
23.8%
% of WDNA's 90 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 1.9% | 1.9% |
|
BRIDGEBIO PHARMA, INC. | 1.9% | 2.4% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 1.8% | 1.7% |
|
AMGEN INC | 2.0% | 1.7% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to WDNA
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
|
ASCENDIS PHARMA A/S | 1.8% |
|
PTC THERAPEUTICS INC | 1.8% |
BBP Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.6% |
|
VERACYTE INC | -2.1% |
 |
NOVARTIS AG | -1.7% |
|
LABCORP HOLDINGS | -1.5% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |